The body's perfect form is built on health, not shortcuts that leave scars.
Em academias e grupos de redes sociais, uma droga aprovada para perda de peso tornou-se o centro de uma experiência coletiva e não supervisionada: a tirzepatida está sendo combinada com esteroides anabolizantes, hormônios e peptídeos por pessoas que buscam corpos ideais sem o amparo da medicina. O que circula como 'receitas' entre usuários é, na verdade, uma carga química que o organismo humano não foi testado para suportar. A morte de jovens como o fisiculturista Gabriel Ganley lembra que o custo dessa busca pode ser irreversível — e que a distância entre a promessa estética e o dano silencioso é, muitas vezes, apenas uma questão de tempo.
- A tirzepatida, medicamento para obesidade, está sendo combinada com anabolizantes como oxandrolona e peptídeos em 'protocolos' caseiros disseminados por grupos de fitness nas redes sociais.
- A proximidade com o Paraguai facilita o acesso informal a essas substâncias em Mato Grosso do Sul, alimentando um mercado paralelo que vende sonhos estéticos sem qualquer controle sanitário.
- A médica Dra. Krislere Gomes alerta que essas combinações sobrecarregam coração, fígado e sistema nervoso — e que os sintomas podem demorar semanas ou meses para aparecer, criando uma falsa sensação de segurança enquanto o dano se acumula.
- O fisiculturista Gabriel Ganley morreu em decorrência do uso indiscriminado de substâncias para fins estéticos, tornando-se símbolo concreto das consequências fatais dessa tendência.
- Especialistas exigem avaliação clínica, exames laboratoriais e acompanhamento profissional contínuo, alertando que os efeitos de longo prazo das combinações com peptídeos ainda são completamente desconhecidos.
A tirzepatida, comercializada como Mounjaro e prescrita para perda de peso, virou protagonista de uma experiência perigosa e coletiva. Nas comunidades fitness do Brasil — com destaque para o Mato Grosso do Sul, onde a fronteira com o Paraguai facilita o acesso a substâncias sem receita —, o medicamento está sendo misturado com esteroides anabolizantes, hormônios e peptídeos. As combinações circulam em grupos de redes sociais como se fossem fórmulas inofensivas, trocadas entre usuários que buscam eliminar gordura sem perder massa muscular.
A médica Dra. Krislere Gomes da Silva acompanha essa tendência com preocupação crescente. Ela observa especialmente mulheres combinando tirzepatida com oxandrolona sem qualquer exame prévio ou acompanhamento clínico. O problema central, segundo ela, não é o uso dos medicamentos em si, mas a ausência total de supervisão: sem hemograma, sem avaliação do histórico de saúde, sem saber se o organismo suporta a carga. O coração se sobrecarrega, o fígado acumula estresse duplo, o trato gastrointestinal inflama — e o sistema nervoso registra tudo isso em silêncio.
O que torna a situação ainda mais grave é o intervalo entre o uso e os sintomas. Uma pessoa pode se sentir bem por semanas ou meses, enquanto danos irreversíveis se instalam. Muitos usuários também tomam antidepressivos ou carregam condições cardíacas não diagnosticadas, multiplicando os riscos de formas que nenhum estudo ainda calculou. Os peptídeos, cada vez mais populares nas redes, somam outra camada de incerteza: simplesmente não existem dados sobre seus efeitos a longo prazo.
A cadeia de abastecimento é informal e movida pelo lucro. Substâncias compradas no Paraguai ou pela internet são reembaladas como 'programas completos de emagrecimento' e vendidas sem qualquer responsabilidade sobre o que pode dar errado. O jovem fisiculturista Gabriel Ganley morreu em decorrência do uso indiscriminado dessas substâncias — um caso que não é exceção, mas advertência. Para a Dra. Gomes, a mensagem é direta: o risco não é hipotético. Ele já está acontecendo.
A weight-loss drug meant to help people shed pounds has become the centerpiece of a dangerous experiment. Tirzepatida, marketed as Mounjaro, is being mixed with anabolic steroids, hormones, and peptides in a growing trend that plays out across social media fitness groups and private channels. Users share recipes—combinations designed to strip fat while preserving muscle—as though they were trading cookie formulas. The practice has taken particular hold in Mato Grosso do Sul, where proximity to Paraguay makes acquiring these substances easier than filling a prescription.
Dr. Krislere Gomes da Silva watches this unfold with alarm. The physician sees the pattern most clearly among women combining tirzepatida with oxandrolone, an anabolic steroid well-known in fitness circles. What troubles her most is not the drugs themselves, but the way they are being used: alone, without blood work, without clinical evaluation, without any sense of whether a person's body can tolerate the load. "It can work," she explains, "but only with medical guidance. The problem is people are doing this on their own, with no tests, no clinical assessment, no idea if their body can handle this combination."
The risks are not theoretical. When these substances mix, they overwhelm the body's systems. The heart strains. The liver—already processing tirzepatida—faces additional burden from the steroids. The gastrointestinal tract becomes inflamed. The nervous system registers the stress. What makes this particularly insidious is the delay. A person can feel fine for weeks or months, building a false sense of safety, while damage accumulates silently. By the time symptoms appear, the harm may be irreversible. Some anabolics like oxandrolone trigger inflammation and metabolic chaos that compounds the problem. Add in the fact that many people taking these combinations are also on antidepressants or carry undiagnosed heart conditions or cancer risk, and the danger multiplies in ways no one has calculated.
The supply chain is informal and profit-driven. People buy substances in Paraguay or through internet channels, then repackage them as complete weight-loss programs, selling the dream without selling the truth about what could go wrong. Clinics market these "procedures" as finished products, thinking about revenue rather than the person's actual health. The combinations circulating most widely pair tirzepatida with oxandrolone, but also with drugs known by street names—Deca, Dura, Masteron—familiar to anyone in the bodybuilding world. The logic is sound on paper: use the steroid to prevent muscle loss while the tirzepatida burns fat. In practice, the body is being asked to process multiple competing signals without rest or medical supervision.
Peptides add another layer of uncertainty. These substances have gained popularity on social media, but long-term studies simply do not exist. No one knows how the body will respond five years from now, or ten. Dr. Gomes emphasizes that anabolics are not forbidden in medicine—they have legitimate uses—but those uses require careful selection, regular lab work, and constant monitoring. The gap between that standard and what is happening now is vast.
The human cost has already been measured. Gabriel Ganley, a young bodybuilder, died after indiscriminate use of substances for aesthetic gain. His death is not an anomaly or a worst-case scenario that happens to someone else. It is a marker of what happens when the pursuit of a perfect body overrides the body's actual capacity to survive. Dr. Gomes returns to this point as she closes: imagine people mixing anabolics, peptides, and tirzepatida without guidance, without knowing what comes next. The risk is not theoretical. It is serious, and it is now.
Citas Notables
It can work, but only with medical guidance. The problem is people are doing this on their own, with no tests, no clinical assessment, no idea if their body can handle this combination.— Dr. Krislere Gomes da Silva
The body perfeito is made with health. There is no point in pursuing a magical procedure and then causing irreversible damage.— Dr. Krislere Gomes da Silva
La Conversación del Hearth Otra perspectiva de la historia
Why is tirzepatida specifically becoming the anchor drug in these combinations? Why not just use steroids alone?
Tirzepatida works on appetite and metabolism in a way steroids don't. It makes you lose fat fast. Steroids alone can build muscle, but they don't necessarily strip the fat the way people want now. The combination promises both at once—the dream of transformation without sacrifice.
And the people doing this—are they aware of the risks, or are they genuinely surprised when doctors warn them?
Both. Some know it's risky and accept it. Others genuinely believe that if they feel fine today, they are fine. The delayed symptoms create a trap. You feel great for months, so you think the warnings don't apply to you.
Dr. Gomes mentions that people with pre-existing conditions don't even know they're at higher risk. How does that happen?
No screening. No conversation with a doctor. Someone sees a post online, buys a package, starts taking it. If you have undiagnosed high blood pressure or a family history of heart disease, you have no way of knowing you're walking into danger.
The Paraguay connection—is that just about cost, or is there something else?
Cost matters, but it's also about access. In Paraguay, these drugs are available without the restrictions Brazil has. It's a short drive for people in that region. It creates a pipeline.
What would actually stop this trend?
Education, but real education—not just warnings. People need to understand that the damage happens invisibly. And they need access to legitimate medical supervision that doesn't judge them for wanting to change their body. Right now, the choice feels like: hide it from a doctor, or don't do it at all.
Is there any scenario where these combinations are safe?
Under strict medical supervision, with baseline testing, regular monitoring, and someone watching for early signs of damage—maybe. But that's not what's happening. What's happening is the opposite of that.